Convergence Investment Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-832
| Closed | -$20K | – | 700 |
|
|
2018
Q1 | $20K | Buy |
+832
| New | +$20K | ﹤0.01% | 596 |
|
|
2015
Q2 | – | Sell |
-8,540
| Closed | -$228K | – | 399 |
|
|
2015
Q1 | $228K | Sell |
8,540
-1,208
| -12% | -$32.3K | 0.03% | 340 |
|
|
2014
Q4 | $206K | Sell |
9,748
-194
| -2% | -$4.1K | 0.03% | 337 |
|
|
2014
Q3 | $237K | Buy |
9,942
+1,216
| +14% | +$29K | 0.03% | 328 |
|
|
2014
Q2 | $202K | Sell |
8,726
-4,064
| -32% | -$94.1K | 0.03% | 351 |
|
|
2014
Q1 | $292K | Sell |
12,790
-4,380
| -26% | -$100K | 0.04% | 305 |
|
|
2013
Q4 | $317K | Sell |
17,170
-3,290
| -16% | -$60.7K | 0.05% | 300 |
|
|
2013
Q3 | $346K | Sell |
20,460
-5,370
| -21% | -$90.8K | 0.07% | 225 |
|
|
2013
Q2 | $400K | Buy |
+25,830
| New | +$400K | 0.1% | 217 |
|